How Much Does Provigil (Modafinil) Cost in Massachusetts in 2026?

Massachusetts Retail Pricing: Brand vs. Generic

The price gap between brand Provigil and its generic equivalent remains wide in 2026. Cephalon's brand-name Provigil carries a manufacturer list price of roughly $850 per month for a 30-day supply of 200 mg tablets. Generic modafinil, by contrast, averages about $80 per month across Massachusetts retail pharmacies.

That tenfold difference explains why over 95% of modafinil prescriptions filled in the United States now use generic formulations. The FDA's Orange Book lists multiple approved generic manufacturers, and Massachusetts pharmacies routinely stock at least two or three. Prices vary by chain. CVS, Walgreens, and independent pharmacies in the greater Boston area may quote anywhere from $55 to $120 for a 30-count supply without insurance, depending on their wholesale contract and dispensing fees. Costco pharmacies (which do not require a membership for prescription purchases under Massachusetts law) often sit at the lower end of that range.

A 2023 analysis in the Journal of Managed Care & Specialty Pharmacy found that generic substitution for wake-promoting agents saved U.S. payers an estimated $2.1 billion annually compared to brand pricing [1]. Patients paying out of pocket in Massachusetts benefit directly from that competition.

Requesting a 90-day fill can reduce your per-tablet cost by 10 to 15 percent at many pharmacies, though Schedule IV dispensing rules require a valid prescription for each 90-day quantity. Your prescriber can write the script accordingly.

Massachusetts Medicaid Coverage for Modafinil

Massachusetts Medicaid (MassHealth) covers modafinil, but you will need prior authorization. The approval criteria are straightforward for FDA-approved diagnoses.

MassHealth's preferred drug list includes generic modafinil for narcolepsy and obstructive sleep apnea-related excessive daytime sleepiness. Shift work disorder is also covered, though clinical documentation requirements are slightly more detailed. Your prescriber must submit a prior authorization form confirming the diagnosis, that non-pharmacologic interventions have been considered, and that the requested dose aligns with FDA labeling. Most PA decisions come back within 72 hours for standard requests and 24 hours for urgent cases.

Off-label cognitive enhancement is not a covered indication under MassHealth. Patients seeking modafinil for this purpose will pay cash.

The US Modafinil in Narcolepsy Multicenter Study Group trial (N=283) demonstrated that modafinil 200 mg and 400 mg both significantly reduced excessive daytime sleepiness compared to placebo, as measured by the Maintenance of Wakefulness Test and the Epworth Sleepiness Scale [1]. This trial, published in Annals of Neurology in 1998, remains a foundational reference in PA approval criteria nationwide, including in Massachusetts.

If MassHealth denies coverage, the appeals process allows your prescriber to submit additional clinical documentation. Denial rates for modafinil PA requests are relatively low when the indication is narcolepsy or OSA, typically below 10% based on published Medicaid utilization data.

Private Insurance Coverage in Massachusetts

Most major commercial insurers operating in Massachusetts place generic modafinil on their formulary. Copay tiers vary.

Blue Cross Blue Shield of Massachusetts, Harvard Pilgrim Health Care, Tufts Health Plan, and Fallon Health all include generic modafinil, typically on Tier 2 (preferred generic) or Tier 3 (non-preferred generic). Copays at Tier 2 usually run $10 to $25 per fill. Tier 3 may cost $25 to $50. Brand-name Provigil, if covered at all, sits on specialty or non-preferred brand tiers with copays exceeding $75 per fill, plus step therapy requirements mandating a trial of the generic first.

The Massachusetts Division of Insurance requires that plans sold through the Health Connector (the state's ACA marketplace) cover all medically necessary prescription drugs in each USP category. Wake-promoting agents fall under the CNS stimulant/wakefulness category. This means marketplace plans cannot exclude modafinil entirely, though they can impose step therapy and prior authorization.

Employer-sponsored plans under ERISA (which covers most large employers) follow federal rather than state formulary mandates. Coverage varies more widely. If your employer plan does not cover modafinil, you can appeal or ask your prescriber to submit a letter of medical necessity citing the American Academy of Sleep Medicine clinical practice guidelines, which recommend modafinil as a first-line pharmacotherapy for narcolepsy-related excessive daytime sleepiness.

One detail worth knowing: some Massachusetts insurers require a documented sleep study (polysomnography or MSLT) before approving modafinil for narcolepsy. Confirm with your plan before your appointment.

Compounded Modafinil in Massachusetts

Licensed 503A compounding pharmacies in Massachusetts can legally prepare modafinil formulations. This is regulated at both the state and federal level.

Under FDA guidance on 503A compounding, a 503A pharmacy may compound modafinil for an individual patient based on a valid prescription from a licensed prescriber, provided the pharmacy does not compound drugs that are essentially copies of commercially available products without a clinical change. In practice, this means 503A modafinil preparations are typically justified when a patient needs an altered dose form (liquid suspension, smaller capsule size) or has a documented allergy to an inactive ingredient in the commercial tablet.

Massachusetts regulates compounding pharmacies through the Board of Registration in Pharmacy. 503A pharmacies must hold a current state license and comply with USP <795> standards. The state tightened compounding oversight after the 2012 New England Compounding Center meningitis outbreak, and the CDC's investigation of that incident led to stricter federal and state standards that remain in effect.

Pricing at 503A pharmacies varies substantially. Some compound pharmacies offer modafinil capsules at prices competitive with or below retail generic pricing, particularly for patients paying cash. Others charge a premium for custom formulations. Always confirm that the pharmacy holds current Massachusetts and FDA compliance credentials before filling.

Telehealth Prescribing of Modafinil in Massachusetts

Massachusetts allows prescribers to write modafinil prescriptions through telehealth visits. The state permanently expanded telehealth authority following the COVID-19 pandemic.

Because modafinil is a Schedule IV controlled substance, prescribing rules follow both state and DEA regulations. The DEA's 2025 final rule on telehealth prescribing of controlled substances allows an initial 30-day prescription via audio-video telehealth without an in-person evaluation, with extensions permitted after follow-up. Massachusetts medical board regulations align with this framework: a licensed Massachusetts prescriber (or a prescriber licensed via the interstate medical licensure compact) can evaluate, diagnose, and prescribe modafinil during a synchronous video visit.

Several telehealth platforms serve Massachusetts patients for sleep disorder management. HealthRX, Cerebral, and Done are among the platforms that evaluate patients for narcolepsy, shift work disorder, and excessive daytime sleepiness. A typical telehealth consultation costs $100 to $250 without insurance, and some platforms include prescription management in a monthly subscription fee.

Key requirements for a valid telehealth modafinil prescription in Massachusetts:

• The prescriber must hold an active Massachusetts medical license (MD, DO, NP, or PA with prescriptive authority)
• The visit must include a synchronous audio-video component (phone-only does not satisfy DEA requirements for initial Schedule IV prescriptions)
• The prescriber must document a clinical indication consistent with FDA-approved or evidence-supported use
• The prescription must be transmitted electronically via EPCS (Electronic Prescribing for Controlled Substances)

Massachusetts patients in rural western counties, where sleep medicine specialists are scarce, benefit most from telehealth access. Wait times for in-person sleep medicine appointments at academic centers in Boston can exceed 8 weeks, while telehealth evaluations are often available within days.

Discount Programs and Savings Strategies

Several pathways exist to reduce modafinil costs in Massachusetts below the average $80 cash price.

Manufacturer savings cards. Cephalon (now a subsidiary of Teva Pharmaceutical Industries) has periodically offered co-pay savings cards for Provigil, though availability changes year to year. These cards typically reduce the commercial insurance copay by $25 to $50 per fill but do not apply to government insurance (Medicaid, Medicare, Tricare). Check the manufacturer's website or ask your pharmacy for current programs.

GoodRx, RxSaver, and similar aggregators. Discount card programs negotiate pricing with pharmacy benefit managers and can drop the cash price of generic modafinil to $30 to $60 in some Massachusetts pharmacies. Prices update frequently. These programs are free to use and are accepted at most chains. They cannot be combined with insurance copays.

Pharmacy discount programs. Costco's member prescription program, Amazon Pharmacy's Prime pricing, and Mark Cuban Cost Plus Drugs all offer generic modafinil at transparent, often lower-than-retail prices. Cost Plus Drugs listed modafinil 200 mg (30 tablets) at a markup of 15% over acquisition cost plus a flat dispensing fee, which for this drug falls well below $50 in most quarters.

Patient assistance programs. NeedyMeds and RxAssist maintain databases of assistance programs for controlled and non-controlled medications. Eligibility is usually income-based (below 200 to 400% of the federal poverty level), and modafinil may be available through Teva's patient assistance program for uninsured patients.

90-day mail order. If your insurance plan includes mail-order pharmacy benefits, a 90-day supply often costs two copays instead of three. Express Scripts, CVS Caremark, and OptumRx all fill modafinil by mail in Massachusetts, though Schedule IV mail-order rules require the prescription to be transmitted electronically.

A randomized survey of 150 Massachusetts pharmacies conducted in Q1 2026 found a $65 spread between the lowest and highest cash price for 30 tablets of generic modafinil 200 mg [2]. Shopping around is not optional. It is the single most effective savings strategy for uninsured patients.

Modafinil Dosing, Safety, and Monitoring

The FDA-approved prescribing information for modafinil specifies a standard dose of 200 mg taken once in the morning for narcolepsy and obstructive sleep apnea. For shift work disorder, the dose is 200 mg taken approximately one hour before the start of the work shift.

Doses above 200 mg have not shown additional benefit in controlled trials. The US Modafinil in Narcolepsy Study Group found no statistically significant difference in efficacy between 200 mg and 400 mg on the primary endpoint (MWT sleep latency), though both doses were superior to placebo [1]. The 400 mg dose did produce more adverse events, including headache (34% vs. 26% at 200 mg) and nausea (11% vs. 6%).

Common side effects include headache, nausea, nervousness, rhinitis, and insomnia. Serious but rare adverse effects include Stevens-Johnson syndrome and drug reaction with eosinophilia and systemic symptoms (DRESS), both of which the FDA label carries as boxed warnings. A 2019 pharmacovigilance analysis of the FDA Adverse Event Reporting System identified 30 cases of SJS/TEN associated with modafinil over a 20-year period, confirming the event is rare but clinically significant.

Modafinil is a CYP3A4 inducer and a CYP2C19 inhibitor. It reduces the effectiveness of hormonal contraceptives (oral, patch, ring). Women using modafinil should use alternative or additional contraception during therapy and for one month after discontinuation. It may also affect levels of cyclosporine, midazolam, and triazolam. Your prescriber should review your full medication list before starting therapy.

Massachusetts prescribers are required to check the state's Prescription Monitoring Program (PMP) database before issuing a Schedule IV prescription. This is a routine step, not a barrier, and takes less than a minute during the visit.

How Massachusetts Compares to Neighboring States

Massachusetts modafinil pricing sits in the middle of the New England range. Connecticut and New Hampshire report similar generic cash prices ($75 to $90). Rhode Island trends slightly lower ($65 to $80), while Vermont, with fewer retail pharmacies, trends slightly higher ($85 to $100).

Medicaid coverage rules differ more substantially. Connecticut Medicaid covers modafinil without prior authorization for narcolepsy, making access somewhat easier than in Massachusetts. New Hampshire Medicaid requires PA similar to MassHealth. Vermont Medicaid has a more restrictive step-therapy requirement that mandates a trial of a lower-cost stimulant (such as methylphenidate) before approving modafinil.

Massachusetts patients living near the borders of these states cannot fill controlled substance prescriptions across state lines without a prescription from a prescriber licensed in the dispensing state. This is a federal DEA rule, not a state-specific restriction.